NCT06545942
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06545942
Title Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MOMA Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
Investigative Site #108 Goodyear Arizona 85338 United States Details
Investigative Site #101 La Jolla California 92093 United States Details
Investigative Site #111 San Francisco California 94143 United States Details
Investigative Site #104 Lake Mary Florida 32746 United States Details
Investigative Site #110 St Louis Missouri 63110 United States Details
Investigative Site #103 New York New York 10016 United States Details
Investigative Site #106 New York New York 10065 United States Details
Investigative Site #109 Philadelphia Pennsylvania 19104 United States Details
Investigative Site #107 Myrtle Beach South Carolina 29572 United States Details
Investigative Site #102 Nashville Tennessee 37203 United States Details
Investigative Site #105 San Antonio Texas 78229 United States Details
Investigative Site #112 Fairfax Virginia 22031 United States Details
Investigative Site #114 Barcelona Spain Details
Investigative Site #116 Barcelona Spain Details
Investigative Site #115 Madrid Spain Details
Investigative Site #113 London United Kingdom Details
Investigative Site #117 Manchester United Kingdom Details
Investigative Site #118 Newcastle upon Tyne United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field